The Effect of Rapid-acting Insulin Injected by Needle-free Jet-injection in the Management of Hyperglycaemia in Patients With Diabetes
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2015
Price : $35 *
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 25 Nov 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 17 Mar 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.